Blood Pressure and Metabolic Effects of Acetyl-l-Carnitine in Type 2 Diabetes: DIABASI Randomized Controlled Trial
Article 2018 en
Authors
AP
Aneliya Parvanova
MT
Matias Trillini
MP
Manuel Alfredo Podestà
Abstract
1 min read
Six-month oral ALC supplementation did not affect blood pressure, lipid and glycemic control, insulin sensitivity and kidney function in hypertensive normoalbuminuric and microalbuminuric T2D patients on background statin therapy.
Khalid M. Alkharfy, Nasser M. Al‐Daghri, Shaun Sabico, Abdulaziz M. Al-Othman, Osama Moharram, Majed S. Alokail, Yousef Al‐Saleh, Sudhesh Kumar, George Chrousos
.webp){kind=small}
Discussion(0)
No comments yet. Be the first to comment.